Geneos Wealth Management’s Taylor Morrison TMHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22
Closed -$1.35K 3133
2025
Q2
$1.35K Sell
22
-118
-84% -$6.86K ﹤0.01% 2904
2025
Q1
$8.41K Buy
+140
New +$8.71K ﹤0.01% 2620
2022
Q3
Sell
-2,500
Closed -$61K 2543
2022
Q2
$61K Hold
2,500
﹤0.01% 1196
2022
Q1
$68K Hold
2,500
﹤0.01% 1236
2021
Q4
$87K Hold
2,500
﹤0.01% 1227
2021
Q3
$65K Buy
+2,500
New +$66.2K ﹤0.01% 1365

Other funds holding TMHC

Geneos Wealth Management's TMHC Position: Q3 2025 in Review

Geneos Wealth Management sold out of Taylor Morrison (TMHC) in Q3 2025, closing a stake of 22 shares — an estimated $1.35K sold.

Geneos Wealth Management first reported a position in TMHC in Q3 2021 and held it in 6 quarters. The position peaked at $87K in Q4 2021. 459 funds tracked by Wall St. Rank hold TMHC as of Q3 2025.

  • Geneos Wealth Management reported no remaining Taylor Morrison position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 22 Taylor Morrison shares in Q3 2025, an estimated $1.35K.
  • Geneos Wealth Management first reported a position in Taylor Morrison in Q3 2021 and held it in 6 quarters.
  • Geneos Wealth Management's Taylor Morrison position peaked at $87K in Q4 2021.
  • 459 funds tracked by Wall St. Rank held Taylor Morrison as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.